# The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome

> **NCT01989000** · NA · COMPLETED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 47 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** Gadobutrol
- **DRUG:** [F-18]HX4
- **DRUG:** Gemcitabine
- **RADIATION:** Radiotherapy
- **PROCEDURE:** Pancreaticoduodenectomy

## Key facts

- **NCT ID:** NCT01989000
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2018-06-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01989000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01989000, "The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01989000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*